PulseSight Therapeutics

BiotechnologySeries AFrancepulsesight.com

Latest round

Series A

Last raised

Feb 2025

Total raised

Undisclosed

Investors

3

About PulseSight Therapeutics

Based in France, PulseSight Therapeutics specialises in non-viral, minimally invasive gene therapies for severe retinal diseases, primarily age-related macular degeneration (AMD) and its various forms. The company's proprietary electro-transfection delivery device facilitates the administration of disease-modifying genes directly to the retina. PulseSight's product pipeline includes PST-809 for wet AMD and PST-611 for dry AMD/geographic atrophy, both at advanced stages of preclinical IND-enabling studies.

Who invested in PulseSight Therapeutics

3 investors across 2 rounds

See all investors in PulseSight Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Feb 13, 2025

    Amount

    Undisclosed

    Investors

    Locked

  2. Seed

    Feb 28, 2024

    Amount

    Undisclosed

    Investors

    Locked

Questions about PulseSight Therapeutics

Who invested in PulseSight Therapeutics?

PulseSight Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has PulseSight Therapeutics raised?

PulseSight Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did PulseSight Therapeutics last raise money?

PulseSight Therapeutics's most recent round on record is a Series A, in Feb 2025.

What does PulseSight Therapeutics do?

Based in France, PulseSight Therapeutics specialises in non-viral, minimally invasive gene therapies for severe retinal diseases, primarily age-related macular degeneration (AMD) and its various forms.

Where is PulseSight Therapeutics headquartered?

PulseSight Therapeutics is headquartered in France.

Which VCs invest in companies like PulseSight Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at PulseSight Therapeutics's stage. Their profiles are linked below.

Raising like PulseSight Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.